Showing results (1961-1970 of 2,013) with videos related to

Sort By:
Pageof 202
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 7, 2023
Folium Hibisci Mutabilis extract, a potent autophagy enhancer, exhibits neuroprotective properties in multiple models of neurodegenerative diseasesChang-Long He, Yong Tang, Xue Chen, et al.
Phytotherapy Research : PTR|September 7, 2020
Lychee seed polyphenol protects the blood-brain barrier through inhibiting Aβ(25-35)-induced NLRP3 inflammasome activation via the AMPK/mTOR/ULK1-mediated autophagy in bEnd.3 cells and APP/PS1 miceRui Xiong, Xiao-Gang Zhou, Yong Tang, et al.
Cell Research|December 2, 2020
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal modelsGan Wang, Meng-Li Yang, Zi-Lei Duan, et al.
Science Advances|September 24, 2025
Impaired macroautophagy in oligodendrocyte precursor cells suppresses neuronal plasticity via a senescence-associated signalingHong Chen, Yan-Yun Sun, Qi-Fa Li, et al.
Zoological Research|May 6, 2022
Discovery of a wild, genetically pure Chinese giant salamander creates new conservation opportunitiesJing Chai, Chen-Qi Lu, Mu-Rong Yi, et al.
Neurobiology of Disease|May 27, 2021
Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD miceQi He, Lin Jiang, Yi Zhang, et al.
Medicine|March 2, 2023
Efficacy and safety of Tuina for chronic nonspecific low back pain: A PRISMA-compliant systematic review and meta-analysisJuan Yang, Xuan Zhou, Qingyu Ma, et al.
Ecology Letters|August 6, 2013
Reliable, verifiable and efficient monitoring of biodiversity via metabarcodingYinqiu Ji, Louise Ashton, Scott M Pedley, et al.
BMJ Open|May 19, 2025
Perioperative SARS-CoV-2 infection and postoperative complications: a single-centre retrospective cohort study in ChinaJia Zhan, Fei Zhong, LingYan Dai, et al.
Nature Communications|September 14, 2022
A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinomaWu-Tong Ju, Rong-Hui Xia, Dong-Wang Zhu, et al.
Pageof 202